ARCHIVES

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

NCAB, De Vita Rap Tobacco Industry For Targeting Blacks, Hispanics

October 24, 1986

Frank Torti Named FDA Deputy Commissioner, To Take Leave As Wake Forest Center Director.

April 11, 2008

Sanofi Responds to Criticism From Oncologists

November 8, 2012

Hammer Says “Exciting Times” Should Convince President to Increase Budget, Ok Act Renewal

April 26, 1985

For R01s, 195 or P01s Center Funds Up By $600,000

May 22, 1981

NCI Facing Extended Tie Under Acting Director – Maybe

August 19, 1988